Approval · Notice of Compliance 4606 · 1996
NORPROLAC: Notice of Compliance 4606
Issued June 25, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4606
- Date
- June 25, 1996
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Prolactin inhibitor
Products in this notice
Medicinal ingredients
- QUINAGOLIDE HCL 0.025 MG per TAB
- QUINAGOLIDE HCL 0.05 MG per TAB
- QUINAGOLIDE HCL 0.075 MG per TAB
- QUINAGOLIDE HCL 0.15 MG per TAB